Saltar al contenido
Merck

Ubiquitous selection for mecA in community-associated MRSA across diverse chemical environments.

Nature communications (2020-11-29)
Olga Snitser, Dor Russ, Laura K Stone, Kathy K Wang, Haleli Sharir, Noga Kozer, Galit Cohen, Haim M Barr, Roy Kishony
RESUMEN

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is threatening public health as it spreads worldwide across diverse environments. Its genetic hallmark, the mecA gene, confers resistance to many β-lactam antibiotics. Here, we show that, in addition, mecA provides a broad selective advantage across diverse chemical environments. Competing fluorescently labelled wild-type and mecA-deleted CA-MRSA USA400 strains across ~57,000 compounds supplemented with subinhibitory levels of the β-lactam drug cefoxitin, we find that mecA provides a widespread advantage across β-lactam and non β-lactam antibiotics, non-antibiotic drugs and even diverse natural and synthetic compounds. This advantage depends on the presence of cefoxitin and is strongly associated with the compounds' physicochemical properties, suggesting that it may be mediated by differential compounds permeability into the cell. Indeed, mecA protects the bacteria against increased cell-envelope permeability under subinhibitory cefoxitin treatment. Our findings suggest that CA-MRSA success might be driven by a cell-envelope mediated selective advantage across diverse chemical compounds.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Yoduro de propidio, ≥94.0% (HPLC)
Supelco
Cefoxitin sodium salt